OMNIOX INC
Pioneering oxygen-based therapies that restore health
SAN FRANCISCO, United States · Founded 2015 · $5.8M raised
- Headquarters
- SAN FRANCISCO, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- omniox.com
- Total Funding
- $5.8M
- Last Round
- $5.8M GrantJun 2014
- Rounds
- 4
About
Omniox is an IND-stage biotechnology company developing the H-NOX protein platform into first-in-class OMX oxygen delivery therapeutics. The company's pipeline targets diseases where tissue hypoxia drives pathology, including oncology, cardiovascular conditions, stroke, trauma, and sickle cell disease. Founded on technology from UC Berkeley, Omniox has received grants from the National Cancer Institute, National Institute of Neurological Disorders and Stroke, and the Wellcome Trust.
Summary
OMNIOX INC is a Biotech company based in SAN FRANCISCO, United States, founded in 2015. It has raised $5.8M in total across 4 rounds, most recently a $5.8M Grant round in Jun 2014. Investors include Wavemaker 360, Acadia Woods Partners and Wellcome Trust.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2020
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...